Active ingredientExenatideCat. No. P-E148-001CAS 141732-76-5Family · Pharmaceutical analytical standards
Exenatide
A GLP-1 receptor agonist, the synthetic version of a 39-amino-acid peptide: it increases insulin release and curbs glucagon. Approved in the United States in April 2005, it is injected under the skin in type 2 diabetes. This family brings together the active ingredient.
Did you know?Its model is exendin-4, isolated in 1992 by endocrinologist John Eng from the venomous saliva of a lizard, the Gila monster.
Go to the active ingredient →Active ingredientExenatideCat. No. P-E148-001CAS 141732-76-5No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.